drugset / Trial / NCT02786992
Misoprostol+Oxytocin vs. Carbetocin in CS
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This prospective randomized double-blind clinical trial will be conducted at Ain-Shams University Maternity Hospital, Cairo, Egypt. Patients eligible for elective lower segment cesarean section will be randomized to 2 groups. Group 1: will receive 400 ug misoprostol following + 10 IU oxytocin intravenous slowly after cord clamping. Group 2: will receive 100 ug carbetocin intravenous after cord clamping.
Timeline
- Start
- 2016-05
- Primary completion
- 2020-01
- Completion
- 2020-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbetocin | Peptide | 100 ug | Intravenous |
| Comparator | Misoprostol | Other / unclassified | 400 ug | Other |
| Comparator | Oxytocin | Peptide | 10 iu | Intravenous |
Indications
No indication recorded.